(505) 254-7784 pchelp@pcsanm.org

About Us
Contact Us

Home
Start Here
- Beginner’s Guide
- Next Steps
Meetings
Resources
Education & Info
Annual Conference
Newsletters
Early Detection
- Early Detection
- Free PSA Test

Select Page

Circulating Tumor Cells May Predict Prostate Cancer Survival

by admin_63069 | Nov 27, 2024 | Related Topics

Among patients with hormone-sensitive prostate cancer, circulating tumor cell (CTC) count at the start of treatment may be able to indicate which patients are likely to live longer after treatment, as well as those who may be good candidates for novel therapies and clinical trial enrollment, researchers have found.

What’s New

FDA Receives NDA for 3-Month Version of Leuprolide Mesylate for Advanced Prostate Cancer
Circulating Tumor Cells May Predict Prostate Cancer Survival
Exercise Benefits In Prostate Cancer Active Surveillance
PARP Inhibitors in Metastatic Prostate Cancer
Older Men Increasingly Overtreated for Prostate Cancer

Disclaimers:

PCSANM provides education, information, and support, not medical advice. Please contact your physician for all your medical concerns. No copyrighted material belonging to others is knowingly used without permission. If any is inadvertently used without permission, please contact our office. Articles are selected from a variety of sources to give as wide a range of content as possible. PCSANM does not endorse or approve, and assumes no responsibility for, the content, accuracy, or completeness of the information presented.

2533 Virginia St. NE, Suite C Albuquerque, NM 87110

Phone: (505) 254-7784
Toll Free: (800) 278-7678
Fax: (505) 254-7786

Email: pchelp@pcsanm.org

Donate
Contact Us